Rocket Pharmaceuticals, Inc. Depreciation
Rocket Pharmaceuticals, Inc. (RCKT) reported Depreciation of $100.00 thousand for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2020-08-05
- Rocket Pharmaceuticals, Inc. depreciation for the quarter ending 2020-06-30 was $100.00K, a 0.00% change year-over-year.
- Rocket Pharmaceuticals, Inc. depreciation for the quarter ending 2020-03-31 was $118.00K, a 15.69% increase year-over-year.
- Rocket Pharmaceuticals, Inc. depreciation for the quarter ending 2019-12-31 was $101.00K, a 4.12% increase year-over-year.
- Rocket Pharmaceuticals, Inc. depreciation for the quarter ending 2019-09-30 was $100.00K, a 0.00% change year-over-year.
- Rocket Pharmaceuticals, Inc. depreciation for fiscal 2019 was $426.00K, a 29.09% increase from fiscal 2018.
- Rocket Pharmaceuticals, Inc. depreciation for fiscal 2018 was $330.00K, a 61.76% increase from fiscal 2017.
- Rocket Pharmaceuticals, Inc. depreciation for fiscal 2017 was $204.00K, a 204.48% increase from fiscal 2016.
- Rocket Pharmaceuticals, Inc. depreciation for fiscal 2016 was $67.00K, a 48.89% increase from fiscal 2015.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-06-30 | $100.00K 10-Q · filed 2020-08-05 | $200.00K 10-Q · filed 2020-08-05 | $319.00K derived: sum of 3 quarters · filed 2020-08-05 | $419.00K derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2020-03-31 | $118.00K 10-Q · filed 2020-05-08 | $219.00K derived: sum of 2 quarters · filed 2020-05-08 | $319.00K derived: sum of 3 quarters · filed 2020-05-08 | $419.00K derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-12-31 | $101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $201.00K derived: sum of 2 quarters · filed 2020-03-06 | $301.00K derived: sum of 3 quarters · filed 2020-08-05 | $426.00K 10-K · filed 2020-03-06 | ||||
| 2019-09-30 | $100.00K 10-Q · filed 2019-11-08 | $200.00K derived: sum of 2 quarters · filed 2020-08-05 | $325.00K 10-Q · filed 2019-11-08 | $399.00K derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-06-30 | $100.00K 10-Q · filed 2020-08-05 | $102.00K 10-Q · filed 2019-08-08 | $200.00K 10-Q · filed 2020-08-05 | $204.00K 10-Q · filed 2019-08-08 | $299.00K derived: sum of 3 quarters · filed 2020-08-05 | $399.00K derived: sum of 4 quarters · filed 2020-08-05 | ||
| 2019-03-31 | $102.00K 10-Q · filed 2020-05-08 | $199.00K derived: sum of 2 quarters · filed 2020-05-08 | $299.00K derived: sum of 3 quarters · filed 2020-05-08 | $373.00K derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $197.00K derived: sum of 2 quarters · filed 2020-03-06 | $271.00K derived: sum of 3 quarters · filed 2020-03-06 | $330.00K 10-K · filed 2020-03-06 | ||||
| 2018-09-30 | $100.00K 10-Q · filed 2019-11-08 | $76.00K 10-Q · filed 2018-11-09 | $174.00K derived: sum of 2 quarters · filed 2019-11-08 | $233.00K 10-Q · filed 2019-11-08 | $319.00K derived: sum of 4 quarters · filed 2019-11-08 | |||
| 2018-06-30 | $74.00K 10-Q · filed 2019-08-08 | $157.00K 10-Q · filed 2019-08-08 | $219.00K derived: sum of 3 quarters · filed 2019-08-08 | $280.00K derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $83.00K 10-Q · filed 2019-05-09 | $145.00K derived: sum of 2 quarters · filed 2019-05-09 | $206.00K derived: sum of 3 quarters · filed 2019-05-09 | $259.00K derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $123.00K derived: sum of 2 quarters · filed 2019-03-08 | $176.00K derived: sum of 3 quarters · filed 2019-03-08 | $204.00K 10-K · filed 2019-03-08 | $200.00K 10-K · filed 2018-03-07 | |||
| 2017-09-30 | $61.00K 10-Q · filed 2018-11-09 | $38.00K 10-Q · filed 2017-11-08 | $114.00K derived: sum of 2 quarters · filed 2018-11-09 | $142.00K 10-Q · filed 2018-11-09 | $162.00K 10-Q · filed 2017-11-08 | $98.00K derived: sum of 4 quarters · filed 2019-03-08 | ||
| 2017-06-30 | $53.00K 10-Q · filed 2018-08-14 | $63.00K 10-Q · filed 2017-08-03 | $81.00K 10-Q · filed 2018-08-14 | $124.00K 10-Q · filed 2017-08-03 | $37.00K derived: sum of 3 quarters · filed 2019-03-08 | $76.00K derived: sum of 4 quarters · filed 2019-03-08 | ||
| 2017-03-31 | $28.00K 10-Q · filed 2018-05-11 | $61.00K 10-Q · filed 2017-05-10 | -$16.00K derived: sum of 2 quarters · filed 2019-03-08 | $23.00K derived: sum of 3 quarters · filed 2019-03-08 | $59.00K derived: sum of 4 quarters · filed 2019-03-08 | |||
| 2016-12-31 | -$44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | -$5.00K derived: sum of 2 quarters · filed 2019-03-08 | $31.00K derived: sum of 3 quarters · filed 2019-03-08 | $67.00K 10-K · filed 2019-03-08 | $169.00K 10-K · filed 2017-03-16 | |||
| 2016-09-30 | $39.00K 10-Q · filed 2017-11-08 | $75.00K derived: sum of 2 quarters · filed 2017-11-08 | $111.00K 10-Q · filed 2017-11-08 | $150.00K derived: sum of 4 quarters · filed 2017-11-08 | ||||
| 2016-06-30 | $36.00K 10-Q · filed 2017-08-03 | $72.00K 10-Q · filed 2017-08-03 | $111.00K derived: sum of 3 quarters · filed 2017-08-03 | $117.00K derived: sum of 4 quarters · filed 2017-08-03 | ||||
| 2016-03-31 | $37.00K 10-Q · filed 2017-05-10 | $75.00K derived: sum of 2 quarters · filed 2017-05-10 | $81.00K derived: sum of 3 quarters · filed 2017-05-10 | $82.00K derived: sum of 4 quarters · filed 2017-05-10 | ||||
| 2015-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $44.00K derived: sum of 2 quarters · filed 2017-03-16 | $45.00K derived: sum of 3 quarters · filed 2017-03-16 | $45.00K 10-K · filed 2017-03-16 | ||||
| 2015-09-30 | $6.00K 10-Q · filed 2016-11-09 | $7.00K derived: sum of 2 quarters · filed 2016-11-09 | $7.00K 10-Q · filed 2016-11-09 | $7.00K derived: sum of 4 quarters · filed 2016-11-09 | ||||
| 2015-06-30 | $1.00K 10-Q · filed 2016-08-10 | $1.00K 10-Q · filed 2016-08-10 | $1.00K derived: sum of 3 quarters · filed 2016-08-10 | $1.00K derived: sum of 4 quarters · filed 2016-08-10 | ||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-11 | $0.00 derived: sum of 2 quarters · filed 2016-05-11 | $0.00 derived: sum of 3 quarters · filed 2016-05-11 | $0.00 derived: sum of 4 quarters · filed 2016-05-11 | ||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | $0.00 derived: sum of 2 quarters · filed 2016-03-23 | $0.00 derived: sum of 3 quarters · filed 2016-03-23 | $0.00 10-K · filed 2016-03-23 | ||||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-12 | $0.00 derived: sum of 2 quarters · filed 2015-11-12 | $0.00 10-Q · filed 2015-11-12 | |||||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-07 | $0.00 10-Q · filed 2015-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |